Does FAP Have a Future? Pro / Con "Presentation" - Wolfgang Fendler & Lena Unterrainer
Wolfgang Fendler
At the 2026 UCSF-UCLA PSMA Conference, Wolfgang Fendler presents Y90-FAPI data in sarcoma showing 12% partial responses and 50% disease stabilization across 30 patients with favorable tolerability.
Radiopharmaceuticals in Prostate Cancer Part 4B: Payloads, Carriers, Targets, and Combinations - Michael Morris & Rana McKay
Michael J. Morris
Michael Morris and Rana McKay discuss isotope and carrier selection, combination strategies, and emerging targets in radiopharmaceutical therapy with Philip Kantoff.
